PI3K/mTOR Dual Inhibitor GSK458 and Arsenic Trioxide Exert Synergistic Antitumor Effects against Ovarian Clear-Cell Carcinoma.

Saved in:
Bibliographic Details
Title: PI3K/mTOR Dual Inhibitor GSK458 and Arsenic Trioxide Exert Synergistic Antitumor Effects against Ovarian Clear-Cell Carcinoma.
Authors: Wang Y; Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan.; Department of Obstetrics and Gynecology, The First Affiliated Hospital of Harbin Medical University, Harbin, P.R. China., Kinose Y; Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan., Kasuya K; Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan., Koizumi M; Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan., Shimizu A; Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan., Nakamura K; Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan., Toda A; Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan., Kawano M; Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan., Kodama M; Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan., Hashimoto K; Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan., Sawada K; Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan., Kimura T; Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan.
Source: Molecular cancer therapeutics [Mol Cancer Ther] 2025 Apr 02; Vol. 24 (4), pp. 563-575.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1538-8514
DOI:10.1158/1535-7163.MCT-24-0490